Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
167 participants
INTERVENTIONAL
2015-06-17
2021-05-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators hypothesize that the measure of painful perception will be significantly superior on suicidals attempters compared to non-attempters. It will be the case for recent suicide attempters and former suicide attempters, suggesting a suicidal vulnerability trait. Moreover, the investigators expect that social distress induced by a social exclusion paradigm will be significantly superior on suicide attempters compared to non-attempters.
The aim of the study is to investigate the physical and psychic pain on depressed subjects with or without history of suicide attempts.
After a clinical evaluation (psychiatric symptomatology, personality trait, suicidal dimension), subjects will be submitted to a painful thermic stimulation and will participate at a computer test of social exclusion (named Cyberball).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Blood Biomarkers in Suicidal Behaviour
NCT02855918
Evaluation of the Risk Associated With Impulsivity and Other Neuropsychological Factors on Suicidal Relapse Within Hospital Emergencies
NCT03026387
Qualitative Assessment of the Brief Contact Intervention "Stay in Contact" in Suicide Prevention
NCT03325478
A Future-oriented Group Training for Suicidal Patients
NCT05158946
Social Threat, Adolescent Relationships, and Suicidality Study
NCT07294079
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
First visit : clinical assessment Second visit : pain evaluation and blood sample (from one day to a week maximum after the first visit).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Study participant
All the participants performed blood sample for genetic purpose, psychiatric assessment and pain investigation:
* 81 depressed patients admitted after a recent suicidal act (\<8 days)
* 81 depressed subjects with a past history of suicidal act (\>1month)
* 80 depressed subjects without any personal history of suicidal behaviour
Blood sample for genetic purpose, psychiatric assessment and pain investigation
All the participant will performed the same evaluation and blood analysis:
* A clinical assessment by psychiatrics assessing psychiatric disorder and suicidal behavior
* Thermal stimulation for pain assessment
* Computer game named Cyberball: test of social exclusion
* Self report questionnaire for the assessment of reject sensitivity, relationship style, impulsivity, childhood trauma.
* Routine blood sampling
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Blood sample for genetic purpose, psychiatric assessment and pain investigation
All the participant will performed the same evaluation and blood analysis:
* A clinical assessment by psychiatrics assessing psychiatric disorder and suicidal behavior
* Thermal stimulation for pain assessment
* Computer game named Cyberball: test of social exclusion
* Self report questionnaire for the assessment of reject sensitivity, relationship style, impulsivity, childhood trauma.
* Routine blood sampling
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* came from West Europe, excepted Basque and Sardinian (because of genetics analysis)
* main diagnosis of major depressive episode (DSM V criteria)
* not having take antalgics in the 24 hours before assessment
* received a minimal psychotrope treatment (clinician evaluation)
* Able to understand nature, aims, methodology of the study
* Agree to cooperate in clinical and biological assessment
* Having signed informed consent
81 recent suicide attempters (being hospitalised for suicidal attempts and having realised a suicide attempts 8 days before inclusion) 81 former suicide attempters (having realised in his lifetime a suicide attempt, one month before inclusion)
Exclusion Criteria
* Current algic and chronic neurologic disease
* Current or actual treatment by tricyclic antidepressant and Serotonin and norepinephrine reuptake inhibitors(SNRIs)
* Pregnancy
* Patients on protective measure
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Montpellier Hospital University
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2013-A01029-36
Identifier Type: OTHER
Identifier Source: secondary_id
UF 9185
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.